BNR - CIK 0001792267
Burning Rock Biotech Ltd (BNR) reported revenue of $77.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $77.16M | +9.2% |
| FY 2024 | $70.67M | -6.6% |
| FY 2023 | $75.70M | -7.3% |
| FY 2022 | $81.66M | +2.5% |
| FY 2021 | $79.69M | +21.0% |
| FY 2020 | $65.89M | - |
Burning Rock Biotech Ltd (BNR) reported revenue of $77.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Burning Rock Biotech Ltd's revenue grew from $65.89M to $77.16M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.